(1Z,2E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one O-(2-(dimethylamino)ethyl) oxime

Catalog No. :
ACFCLJ022
CAS No. :
130581-13-4
Molecular Formula :
C19H21FN2O2
Molecular Weight :
328.39

IUPAC Name:(1Z,2E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one O-(2-(dimethylamino)ethyl) oxime

(1Z,2E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one O-(2-(dimethylamino)ethyl) oxime structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$84.00Login to see priceInquiryInquiry
10mg99%$137.00Login to see priceInquiryInquiry
50mg99%$377.00Login to see priceInquiryInquiry
100mg99%$529.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1Z,2E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one O-(2-(dimethylamino)ethyl) oxime
IUPAC Name(1Z,2E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one O-(2-(dimethylamino)ethyl) oxime
Molecular FormulaC19H21FN2O2
Molecular Weight328.39
SMILESFC1=C(C=CC=C1)C(/C=C/C2=CC=C(O)C=C2)=N\OCCN(C)C
InChI KeyVAIOZOCLKVMIMN-PRJWTAEASA-N
SynonymSR-01000944919 | SR-01000944919-1 | DB12177 | OXAZEPAM [JAN] | SR46349 | SR-46349 | Eplivanserin [INN] | Eplivanserin [USAN:INN:BAN] | L001389 | PDSP2_001557 | BDBM81780 | Eplivanserin (USAN/INN) | 4-[(1E,3Z)-3-{[2-(Dimethylamino)ethoxy]imino}-3-(2-fluoro
CAS No.130581-13-4
PubChem CID135456190

Synthetic Route by SureRoute

1. ACFCLJ022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFCLJ022 route product structure diagram
    ACFCLJ022130581-13-4
Inquiry

2. ACFCLJ022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCLJ022 route product structure diagram
    ACFCLJ022130581-13-4
Inquiry

Comments (0)